Aptar Pharma secures approval in US for Bidose nasal drug delivery device

07:32 EDT 19 Mar 2019 | Compelo Medical Devices

Aptar Pharma said the approval marks the first FDA nod and US launch of a prescription drug using its patented Bidose nasal spray delivery system. The company noted

More From BioPortfolio on "Aptar Pharma secures approval in US for Bidose nasal drug delivery device"